Published in Oral Oncol on February 06, 2010
Impact of cellular miRNAs on circulating miRNA biomarker signatures. PLoS One (2011) 2.24
Cooperative and individualistic functions of the microRNAs in the miR-23a~27a~24-2 cluster and its implication in human diseases. Mol Cancer (2010) 2.14
MicroRNAs as potential biomarkers in human solid tumors. Cancer Lett (2012) 1.73
Cell-free Circulating miRNA Biomarkers in Cancer. J Cancer (2012) 1.37
microRNAs and RNA-binding proteins: a complex network of interactions and reciprocal regulations in cancer. RNA Biol (2013) 1.26
MicroRNA-32 (miR-32) regulates phosphatase and tensin homologue (PTEN) expression and promotes growth, migration, and invasion in colorectal carcinoma cells. Mol Cancer (2013) 1.25
Micro-RNAs as diagnostic or prognostic markers in human epithelial malignancies. BMC Cancer (2011) 1.20
MicroRNA-24 targeting RNA-binding protein DND1 in tongue squamous cell carcinoma. FEBS Lett (2010) 1.03
Tumor suppressor miR-24 restrains gastric cancer progression by downregulating RegIV. Mol Cancer (2014) 1.01
miR-24 functions as a tumor suppressor in Hep2 laryngeal carcinoma cells partly through down-regulation of the S100A8 protein. Oncol Rep (2011) 0.99
Differential expression of miRNAs in the serum of patients with high-risk oral lesions. Cancer Med (2012) 0.99
Diagnostic and prognostic value of plasma microRNA deregulation in nasopharyngeal carcinoma. Cancer Biol Ther (2013) 0.96
MicroRNAs in Cancer Biology and Therapy: Current Status and Perspectives. Genes Dis (2014) 0.94
Association between mir-24 and mir-378 in formalin-fixed paraffin-embedded tissues of breast cancer. Int J Clin Exp Pathol (2014) 0.93
Focus on PTEN Regulation. Front Oncol (2015) 0.93
IGF-1R, a target of let-7b, mediates crosstalk between IRS-2/Akt and MAPK pathways to promote proliferation of oral squamous cell carcinoma. Oncotarget (2014) 0.92
MiR-24 promotes the survival of hematopoietic cells. PLoS One (2013) 0.92
Involvement of microRNA-24 and DNA methylation in resistance of nasopharyngeal carcinoma to ionizing radiation. Mol Cancer Ther (2014) 0.90
Mir-24-3p downregulation contributes to VP16-DDP resistance in small-cell lung cancer by targeting ATG4A. Oncotarget (2015) 0.89
MicroRNAs in Head and Neck Cancer. Int J Dent (2013) 0.88
Noninvasive micromarkers. Clin Chem (2014) 0.86
MicroRNA-24 modulates aflatoxin B1-related hepatocellular carcinoma prognosis and tumorigenesis. Biomed Res Int (2014) 0.85
MicroRNAs as Important Players and Biomarkers in Oral Carcinogenesis. Biomed Res Int (2015) 0.82
EGF up-regulates miR-31 through the C/EBPβ signal cascade in oral carcinoma. PLoS One (2014) 0.82
Methylated DNA and microRNA in body fluids as biomarkers for cancer detection. Int J Mol Sci (2013) 0.81
Characterization of miR-146a and miR-155 in blood, tissue and cell lines of head and neck squamous cell carcinoma patients and their impact on cell proliferation and migration. J Cancer Res Clin Oncol (2015) 0.79
Onco-miR-24 regulates cell growth and apoptosis by targeting BCL2L11 in gastric cancer. Protein Cell (2016) 0.78
miR-24 and miR-205 expression is dependent on HPV onco-protein expression in keratinocytes. Virology (2013) 0.77
Multitargeting activity of miR-24 inhibits long-term melatonin anticancer effects. Oncotarget (2016) 0.77
Circulating miR-223 in Oral Cancer: Its Potential as a Novel Diagnostic Biomarker and Therapeutic Target. PLoS One (2016) 0.76
circRNA_100290 plays a role in oral cancer by functioning as a sponge of the miR-29 family. Oncogene (2017) 0.76
Increased expression of miR-24 is associated with acute myeloid leukemia with t(8;21). Int J Clin Exp Pathol (2014) 0.75
MicroRNA expression and its association with DNA repair in preimplantation embryos. J Reprod Dev (2016) 0.75
Overexpression of microRNA-24 increases the sensitivity to paclitaxel in drug-resistant breast carcinoma cell lines via targeting ABCB9. Oncol Lett (2016) 0.75
microRNA from brush biopsy to characterize oral squamous cell carcinoma epithelium. Cancer Med (2016) 0.75
The miR-24-3p/p130Cas: a novel axis regulating the migration and invasion of cancer cells. Sci Rep (2017) 0.75
Review of MicroRNA Proposed Target Genes in Oral Cancer. Part II. J Oral Maxillofac Res (2011) 0.75
Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat Cell Biol (2008) 7.37
Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res (2008) 3.32
miR-31 ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in head and neck carcinoma. Cancer Res (2010) 2.18
The epithelial-mesenchymal transition mediator S100A4 maintains cancer-initiating cells in head and neck cancers. Cancer Res (2010) 1.39
Genome-wide profiling of oral squamous cell carcinoma. J Pathol (2004) 1.33
Galectin-1-mediated tumor invasion and metastasis, up-regulated matrix metalloproteinase expression, and reorganized actin cytoskeletons. Mol Cancer Res (2009) 1.30
Combinational polymorphisms of four DNA repair genes XRCC1, XRCC2, XRCC3, and XRCC4 and their association with oral cancer in Taiwan. J Oral Pathol Med (2008) 1.29
The evolving transcriptome of head and neck squamous cell carcinoma: a systematic review. PLoS One (2008) 1.18
Elimination of head and neck cancer initiating cells through targeting glucose regulated protein78 signaling. Mol Cancer (2010) 1.16
miRNA-491-5p and GIT1 serve as modulators and biomarkers for oral squamous cell carcinoma invasion and metastasis. Cancer Res (2013) 1.14
miR-181 as a putative biomarker for lymph-node metastasis of oral squamous cell carcinoma. J Oral Pathol Med (2011) 1.14
Targeting galectin-1 in carcinoma-associated fibroblasts inhibits oral squamous cell carcinoma metastasis by downregulating MCP-1/CCL2 expression. Clin Cancer Res (2011) 1.12
Cucurbitacin I suppressed stem-like property and enhanced radiation-induced apoptosis in head and neck squamous carcinoma--derived CD44(+)ALDH1(+) cells. Mol Cancer Ther (2010) 1.11
MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells. J Pathol (2011) 1.08
Increased expression of amyloid precursor protein in oral squamous cell carcinoma. Int J Cancer (2004) 1.07
miR-134 induces oncogenicity and metastasis in head and neck carcinoma through targeting WWOX gene. Int J Cancer (2013) 1.06
The implication of osteopontin (OPN) expression and genetic polymorphisms of OPN promoter in oral carcinogenesis. Oral Oncol (2010) 1.05
Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma. Head Neck (2011) 1.05
Array-comparative genomic hybridization to detect genomewide changes in microdissected primary and metastatic oral squamous cell carcinomas. Mol Carcinog (2006) 1.05
Serine protease inhibitor (SERPIN) B1 promotes oral cancer cell motility and is over-expressed in invasive oral squamous cell carcinoma. Oral Oncol (2009) 1.02
Correlation between functional genotypes in the matrix metalloproteinases-1 promoter and risk of oral squamous cell carcinomas. J Oral Pathol Med (2004) 1.02
Functional polymorphism in NFKB1 promoter is related to the risks of oral squamous cell carcinoma occurring on older male areca (betel) chewers. Cancer Lett (2006) 1.01
The association between genetic polymorphism and the processing efficiency of miR-149 affects the prognosis of patients with head and neck squamous cell carcinoma. PLoS One (2012) 1.01
Association of expression aberrances and genetic polymorphisms of lysyl oxidase with areca-associated oral tumorigenesis. Clin Cancer Res (2007) 1.00
Detection and screening of oral cancer and pre-cancerous lesions. J Chin Med Assoc (2009) 1.00
IFN-induced protein with tetratricopeptide repeats 2 inhibits migration activity and increases survival of oral squamous cell carcinoma. Mol Cancer Res (2008) 0.99
Passenger strand miRNA miR-31* regulates the phenotypes of oral cancer cells by targeting RhoA. Oral Oncol (2012) 0.99
The biphasic differential expression of the cellular membrane protein, caveolin-1, in oral carcinogenesis. J Oral Pathol Med (2003) 0.98
Cytotoxicity of phenolic acid phenethyl esters on oral cancer cells. Cancer Lett (2004) 0.98
Association of epidermal growth factor receptor (EGFR) gene copy number amplification with neck lymph node metastasis in areca-associated oral carcinomas. Oral Oncol (2007) 0.97
MDM2 SNP 309 and p53 codon 72 polymorphisms are associated with the outcome of oral carcinoma patients receiving postoperative irradiation. Radiother Oncol (2008) 0.97
Areca (betel) nut extract activates mitogen-activated protein kinases and NF-kappaB in oral keratinocytes. Int J Cancer (2005) 0.97
Tid1 functions as a tumour suppressor in head and neck squamous cell carcinoma. J Pathol (2009) 0.96
Interaction between HSP60 and beta-catenin promotes metastasis. Carcinogenesis (2009) 0.96
MicroRNA aberrances in head and neck cancer: pathogenetic and clinical significance. Curr Opin Otolaryngol Head Neck Surg (2013) 0.96
Ripe areca nut extract induces G1 phase arrests and senescence-associated phenotypes in normal human oral keratinocyte. Carcinogenesis (2006) 0.96
Genetic and epigenetic alterations of the blood group ABO gene in oral squamous cell carcinoma. Int J Cancer (2004) 0.95
Increase of disintergin metalloprotease 10 (ADAM10) expression in oral squamous cell carcinoma. Cancer Lett (2005) 0.94
Neck abscess and necrotizing fasciitis caused by Salmonella infection: a report of 2 cases. J Oral Maxillofac Surg (2007) 0.93
Functional genotype in matrix metalloproteinases-2 promoter is a risk factor for oral carcinogenesis. J Oral Pathol Med (2004) 0.93
Association between lysyl oxidase polymorphisms and oral submucous fibrosis in older male areca chewers. J Oral Pathol Med (2008) 0.93
Fatty-acid-binding protein 5 promotes cell proliferation and invasion in oral squamous cell carcinoma. J Oral Pathol Med (2009) 0.92
Tumor necrosis factor-alpha promoter polymorphism is associated with susceptibility to oral squamous cell carcinoma. J Oral Pathol Med (2005) 0.92
miR-221 and miR-222 expression increased the growth and tumorigenesis of oral carcinoma cells. J Oral Pathol Med (2011) 0.92
Establishment of OC3 oral carcinoma cell line and identification of NF-kappa B activation responses to areca nut extract. J Oral Pathol Med (2004) 0.92
miR-146a enhances the oncogenicity of oral carcinoma by concomitant targeting of the IRAK1, TRAF6 and NUMB genes. PLoS One (2013) 0.91
Association between the rs2910164 polymorphism in pre-mir-146a and oral carcinoma progression. Oral Oncol (2011) 0.91
miR-211 promotes the progression of head and neck carcinomas by targeting TGFβRII. Cancer Lett (2013) 0.91
Src family kinases mediate betel quid-induced oral cancer cell motility and could be a biomarker for early invasion in oral squamous cell carcinoma. Neoplasia (2008) 0.91
Surgical outcomes and prognostic factors of oral cancer associated with betel quid chewing and tobacco smoking in Taiwan. Oral Oncol (2010) 0.91
Impact of diabetes mellitus on the prognosis of patients with oral squamous cell carcinoma: a retrospective cohort study. Ann Surg Oncol (2010) 0.90
Involvement of microtubule-associated protein 2 (MAP2) in oral cancer cell motility: a novel biological function of MAP2 in non-neuronal cells. Biochem Biophys Res Commun (2007) 0.90
Arecoline-mediated inhibition of AMP-activated protein kinase through reactive oxygen species is required for apoptosis induction. Oral Oncol (2011) 0.89
Rapidly growing mass in mandibular gingiva. J Oral Maxillofac Surg (2004) 0.89
Association between the polymorphisms in exon 12 of hypoxia-inducible factor-1alpha and the clinicopathological features of oral squamous cell carcinoma. Oral Oncol (2010) 0.89
Hydroxychavicol modulates benzo[a]pyrene-induced genotoxicity through induction of dihydrodiol dehydrogenase. Toxicol Lett (2004) 0.89
Curcumin upregulates insulin-like growth factor binding protein-5 (IGFBP-5) and C/EBPalpha during oral cancer suppression. Int J Cancer (2010) 0.88
Areca nut extract induced oxidative stress and upregulated hypoxia inducing factor leading to autophagy in oral cancer cells. Autophagy (2010) 0.88
miR-31 is upregulated in oral premalignant epithelium and contributes to the immortalization of normal oral keratinocytes. Carcinogenesis (2014) 0.88
Detection of copy number amplification of cyclin D1 (CCND1) and cortactin (CTTN) in oral carcinoma and oral brushed samples from areca chewers. Oral Oncol (2009) 0.88
Copy number amplification of 3q26-27 oncogenes in microdissected oral squamous cell carcinoma and oral brushed samples from areca chewers. J Pathol (2005) 0.87
Role of SIRT1 in regulation of epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis. Mol Cancer (2014) 0.87
Presurgical serum levels of matrix metalloproteinase-9 and vascular endothelial growth factor in oral squamous cell carcinoma. Oral Oncol (2009) 0.86
Serum decoy receptor 3 level: a predictive marker for nodal metastasis and survival among oral cavity cancer patients. Head Neck (2011) 0.86
Expression of phosphorylated Akt in oral carcinogenesis and its induction by nicotine and alkaline stimulation. J Oral Pathol Med (2008) 0.85
Functional -1562 C-to-T polymorphism in matrix metalloproteinase-9 (MMP-9) promoter is associated with the risk for oral squamous cell carcinoma in younger male areca users. J Oral Pathol Med (2007) 0.85
MICA and MICB overexpression in oral squamous cell carcinoma. J Oral Pathol Med (2007) 0.85
Epidermal hyperproliferation in mice lacking fatty acid transport protein 4 (FATP4) involves ectopic EGF receptor and STAT3 signaling. Dev Biol (2010) 0.85
In vitro antimicrobial and anticancer potential of hinokitiol against oral pathogens and oral cancer cell lines. Microbiol Res (2013) 0.85
Overexpression of Rac-1 small GTPase binding protein in oral squamous cell carcinoma. J Oral Maxillofac Surg (2004) 0.85
Pyogenic liver abscess with Prevotella species and Fusobacterium necrophorum as causative pathogens in an immunocompetent patient. J Formos Med Assoc (2009) 0.84
Src-homology 2 domain-containing tyrosine phosphatase 2 promotes oral cancer invasion and metastasis. BMC Cancer (2014) 0.84
Autophagy induction by the 30-100kDa fraction of areca nut in both normal and malignant cells through reactive oxygen species. Oral Oncol (2010) 0.84